Top MedTech Investors for Startups 2026
Find the investors funding medtech startups across medical devices, diagnostics, and AI-driven care. Investor Hunt lists 2,387 medtech investors.
Investor Data Snapshot
MedTech investors in the Investor Hunt database: 2,387
Top countries represented: United States, United Kingdom, Germany, Switzerland, Israel, Canada
Top states and regions represented: Massachusetts, California, New York, Minnesota, Texas, Pennsylvania
Top cities represented: Boston, San Francisco, New York City, Minneapolis, London, Tel Aviv
Top industries covered: Health Care, Medical Devices, Digital Health, Diagnostics, Biotechnology, AI
Data reflects investors currently available in the Investor Hunt database and is updated regularly.
What MedTech Investors Are Actually Funding
MedTech investors fund devices and diagnostics with a clear path through the FDA. The money follows regulatory approval.
Medtech venture is heading for its strongest year since 2021. Companies raised $4.1 billion in the second quarter of 2026, matching the pace set in the first quarter.
AI-enabled companies took 55% of health tech venture funding in 2025, up from 37% the year before. The FDA authorized 258 AI-enabled devices in 2025.
Surgical tools, connected devices, and diagnostics also raise well. GammaTile, an FDA-cleared radiotherapy implant for brain tumors, raised a $100 million round in 2026.
Why MedTech Doesn't Raise Like Software
MedTech, unlike software needs:
Regulatory Path
A device needs FDA clearance or approval before it can sell. That process takes years and can ask for more studies at any point.
Clinical Evidence
Investors want trial data showing the device works and is safe. Building that evidence costs money long before there's revenue.
Reimbursement
A device only sells at scale once insurers agree to pay for it. A product with no reimbursement plan has no real market.
Long Timelines
From lab to market runs years, not months, so investors underwrite a much longer wait for revenue.
The Top 6 MedTech Investors
1. Devin Quinlan
- Location: Cambridge, Massachusetts
- Investor types: Venture Capital, Accelerator, Private Equity Firm
- Markets include: Medical Technologies, Health Care, Research and Development, Regenerative Medicine
Quinlan invests out of Cambridge. His tags are the most health-focused on this list, spanning care, research, and regenerative medicine, which fits founders building genuine clinical technology.
2. Rick Yang
- Location: San Francisco, California
- Investor types: Venture Capital, Private Equity Firm, Angel/Individual
- Markets include: Medical Technologies, Health Care, AI, FinTech, Emerging Technology
Yang is a General Partner at NEA, one of the largest venture firms in the US, where he has invested since 2007. His checks run from $50K to $50 million, and his healthcare work sits alongside AI and consumer.
3. Scotland Stevens
- Location: New York City, New York
- Investor types: Venture Capital, Private Equity Firm, Investor
- Markets include: Medical Technologies, Health Care, Research and Development, Drug Discovery
Stevens invests from New York across health care, R&D, and drug discovery. The tags point to a life-sciences focus rather than pure devices, which fits founders working closer to the science.
4. Gary Swart
- Location: Atherton, California
- Investor types: Venture Capital, Private Equity Firm, Angel/Individual
- Markets include: Medical Technologies, Creative Venture, Patient Care, Health Care
Swart invests out of Atherton and was previously CEO of oDesk. He backs early-stage companies across technology and health, and brings an operator's view to the companies he funds.
5. Philip Chopin
- Location: London, England
- Investor types: Venture Capital, Private Equity Firm, Investor
- Markets include: Medical Technologies, Health Care, Advertising, Emerging Technology
Chopin invests from London across health care and emerging technology. The main European name on this list, and a useful contact for founders raising outside the US.
6. Tony Florence
- Location: New York City, New York
- Investor types: Venture Capital, Private Equity Firm, Angel/Individual
- Markets include: Medical Technologies, Health Care, Advertising, Emerging Technology
Florence is Co-CEO of NEA and one of the most established venture investors in New York. His medical technology coverage sits within a broad portfolio, and he leads larger rounds once a company has real traction.
How Much Do MedTech Investors Invest?
MedTech seed rounds run $1 million to $5 million. Series A runs $5 million to $20 million. Later rounds are far larger, and most medtech capital sits at the growth stage, where Series C and beyond made up nearly 70% of dollars raised in 2026.
Which MedTech Investors Are Right for Your Startup?
MedTech is not one category. An investor who backs surgical robots and one who backs diagnostic software both list medtech, and they fund different companies.
On Investor Hunt, an investor's profile shows every market they cover and the companies they've already funded. A diagnostics founder can find the investors who've backed diagnostics before, and skip the ones who only do devices or digital health.
The past deals show which corner of medtech an investor actually understands.
Frequently Asked Questions
Q: How do medtech startups get funding?
A: Through specialist health VCs, angels, corporate arms of device makers, and government grants like the NIH's SBIR program. Early on, angels and grants fund the prototype and early studies.
Q: How much do medtech startups raise?
A: Seed rounds run $1 to 5 million, Series A $5 to 20 million. Later rounds are much larger, and most medtech capital sits at the growth stage.
Q: Do medtech investors fund pre-revenue startups?
A: Often, yes. Medtech takes years to reach revenue, so investors back a strong team, a clear FDA plan, and early clinical data well before sales.
Q: Why don't generalist VCs invest in medtech?
A: Timelines and regulation. A software VC expects revenue in months. Medtech takes years, needs clinical trials, and depends on FDA approval and reimbursement they aren't set up to judge.
Q: What do medtech investors want to see in a pitch?
A: A realistic FDA strategy, clinical evidence, and a reimbursement plan. A team that has built regulated devices before matters most.
Related Investor Lists
